AstraZeneca

Últimas notícias

Manchetes no idioma original da fonte.

• Sam Fazeli: AstraZeneca's $2 Billion Summit Bet Tests Whether Strategics See What Public Markets Can't (abre em uma nova aba)

  finance.biggo.com · 2 de out. de 2026

• AstraZeneca invests $2bn in Summit Therapeutics, deepening oncology ADC-bispecific ties (abre em uma nova aba)

  TipRanks · 2 de out. de 2026

• AstraZeneca Stocks Moves Lower as Datroway Combination Enters Phase 3 (abre em uma nova aba)

  TradingView · 2 de out. de 2026

• astrazeneca acquired rights to cspc experimental weight-loss drugs for billions (abre em uma nova aba)

  BusinessWorld Online · 2 de out. de 2026

• AstraZeneca PLC, Daiichi Sankyo And Summit Therapeutics Inc. Announce Clinical Collaboration To Evaluate Datroway In Combination With Ivonescimab Across Multiple Tumour Types (abre em uma nova aba)

  marketscreener.com · 2 de out. de 2026

• EU revokes Hansoh's Aumseqa nod after AstraZeneca challenge (abre em uma nova aba)

  FirstWord Pharma · 2 de out. de 2026

• AstraZeneca, Daiichi Sankyo, and Summit to Combine Datroway, Ivonescimab (abre em uma nova aba)

  BioPharm International · 2 de out. de 2026

• AstraZeneca et Daiichi Sankyo s'associent à Summit pour tester une association de médicaments anticancéreux (abre em uma nova aba)

  TradingView · 2 de out. de 2026

• Summit to Pair with AstraZeneca, Daiichi Sankyo to Evaluate Ivonescimab as Combination Therapy (abre em uma nova aba)

  Contract Pharma · 2 de out. de 2026

• AstraZeneca, Daiichi Sankyo partner with Summit to test Datroway-ivonescimab combinations (abre em uma nova aba)

  Dealroom · 2 de out. de 2026

• AstraZeneca Trillion-Pound Valuation: Can the Pipeline Deliver It? (abre em uma nova aba)

  ABC Money · 2 de out. de 2026

• Innovation roundup: Carnegie Mellon in Miami, AstraZeneca's $2B investment (abre em uma nova aba)

  bizjournals.com · 2 de out. de 2026

• Summit partners with AstraZeneca and Daiichi; Eccogene earns $50M milestone (abre em uma nova aba)

  Endpoints News · 2 de out. de 2026

• 
  AstraZeneca deepens Summit ties on ADC-bispecific cancer combo testing pact (abre em uma nova aba)

  Pharmaceutical Technology · 2 de out. de 2026

• Roundup: Novartis & Abogen Enter Licensing and Option Agreement, AstraZeneca and Daiichi Sankyo Enter Clinical Collaboration with Summit Therapeutics (abre em uma nova aba)

  Pharmaceutical Executive · 2 de out. de 2026

• AstraZeneca, Daiichi Sankyo Expand Cancer Push Through Summit Partnership (abre em uma nova aba)

  Benzinga · 2 de out. de 2026

• Rx Rundown: Eli Lilly, AstraZeneca, United Immunity and more (abre em uma nova aba)

  Medical Marketing and Media · 2 de out. de 2026

• 
  Sanofi, Regeneron Expand Immunology Alliance With New Antibodies (abre em uma nova aba)

  Zacks · 2 de out. de 2026

• SMMT Stock Gets Another Catalyst: Summit, AstraZeneca, Daiichi Sankyo Expand Cancer Drug Push (abre em uma nova aba)

  Stocktwits · 2 de out. de 2026

• 
  Summit Teams Up With Daiichi Sankyo, AstraZeneca For Cancer Therapy Trial – CEO Calls It An ‘Important Expansion’ (abre em uma nova aba)

  Stocktwits · 2 de out. de 2026

• 
  J&J's Innovative Medicine Segment in Q3: Key Growth Drivers to Watch (abre em uma nova aba)

  Zacks · 2 de out. de 2026

• People on the Move: Maciej Szymaszek Named Head of Commercial AI Strategy at AstraZeneca (abre em uma nova aba)

  biobuzz.io · 2 de out. de 2026

• AstraZeneca invests USD 2.00 billion and AstraZeneca stock costs EUR 141.25 (abre em uma nova aba)

  AD HOC NEWS · 2 de out. de 2026

• AstraZeneca buys into Summit – this is only the beginning (abre em uma nova aba)

  Biostock · 2 de out. de 2026

• AstraZeneca and Daiichi Sankyo Team With Summit on Datroway Combination Trials (abre em uma nova aba)

  AskTraders · 2 de out. de 2026

• Lung and breast cancers are targets of AstraZeneca (AZN)'s new three-company trial collaboration. (abre em uma nova aba)

  Stock Titan · 2 de out. de 2026

• AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination (abre em uma nova aba)

  srnnews.com · 2 de out. de 2026

• AstraZeneca, Daiichi team with Summit to pair Datroway with ivonescimab in Phase III TNBC push (abre em uma nova aba)

  allsci.com · 2 de out. de 2026

• 
  Summit Therapeutics (SMMT), What Is Behind The Fresh Attention? (abre em uma nova aba)

  Simply Wall St. · 2 de out. de 2026

• Summit Therapeutics to test ivonescimab with AstraZeneca-Daiichi ADC (abre em uma nova aba)

  StreetInsider · 2 de out. de 2026